Zanubrutinib versus bendamustine and rituximab in untreated patients with CLL/SLL Zanubrutinib versus bendamustine and rituximab in untreated patients with CLL/SLL February 2025 Clinical trials Read more
2022 October Covid-19 Thrombopoietin is elevated during COVID-19 and is associated with platelet activation Read more
2022 October Pharma News Axicabtagene ciloleucel receives European nod as second-line treatment for large B-cell lympho... Read more
2022 October Covid-19 Elevated thrombopoietin levels may serve as biomarker for high risk of severe COVID-19 Read more
2022 October Science Anaemia is prevalent and a risk factor for patients with advanced kidney disease Read more
2022 September Clinical trials Abnormal menstrual bleeding in women treated with anticoagulants for venous thromboembolism Read more
2022 September General Increased risk for cardiovascular events associated with immune checkpoint inhibitor therapy Read more
Top
